Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsAddiction psychiatry

Psych · Addiction psychiatry

Benzodiazepine dependence

Also known as Benzodiazepine use disorder · Sedative hypnotic anxiolytic use disorder · BZD dependence · Benzodiazepine withdrawal · Z-drug dependence · Benzodiazepine deprescribing

Exam-exhaustive fellowship topic on benzodiazepine dependence — DSM-5-TR/ICD-11 nosology, GABA-A tolerance and withdrawal including seizures, half-life classification, Z-drugs, structured taper and diazepam substitution, elderly falls and cognition, legitimate short-term use, alcohol and opioid interactions, deprescribing evidence (EMPOWER, Canadian BRZA, joint tapering CPG). FRANZCP-primary, globally tagged.

high18 referencesUpdated 26 July 202615 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Abrupt cessation after continuous benzodiazepine or Z-drug use — risk of seizures, delirium, and severe rebound anxiety; reinstate then controlled taper
  • Withdrawal seizure or delirium — medical emergency; do not leave dependent patients without GABA-A cover after a seizure
  • Combined benzodiazepines with alcohol or opioids — synergistic CNS and respiratory depression and overdose death risk
  • Routine flumazenil in chronic users or mixed overdose — can precipitate seizures; highly selected use only
  • Assuming Z-drugs are non-dependence-forming or safe long-term hypnotics in older adults
  • Elderly patient with falls, confusion, or new cognitive decline on ongoing BZD/Z-drug — review and deprescribe pathway
  • High-potency short-acting agents (e.g. alprazolam) at escalating doses or multiple prescribers — misuse and severe withdrawal risk
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Abrupt cessation after continuous benzodiazepine or Z-drug use — risk of seizures, delirium, and severe rebound anxiety; reinstate then controlled taper
  • Withdrawal seizure or delirium — medical emergency; do not leave dependent patients without GABA-A cover after a seizure
  • Combined benzodiazepines with alcohol or opioids — synergistic CNS and respiratory depression and overdose death risk
  • Routine flumazenil in chronic users or mixed overdose — can precipitate seizures; highly selected use only
  • Assuming Z-drugs are non-dependence-forming or safe long-term hypnotics in older adults
  • Elderly patient with falls, confusion, or new cognitive decline on ongoing BZD/Z-drug — review and deprescribe pathway
  • High-potency short-acting agents (e.g. alprazolam) at escalating doses or multiple prescribers — misuse and severe withdrawal risk
One-line fellowship answer

Benzodiazepine dependence is GABA-A positive-allosteric-modulator adaptation after repeated exposure — physiological tolerance and a withdrawal syndrome that can include seizures — managed by never abrupt-stopping dependent patients, treating the underlying anxiety or insomnia with non-benzodiazepine strategies, and delivering a negotiated gradual taper (often via diazepam substitution), with heightened caution in older adults, Z-drug users, and anyone combining alcohol or opioids.[1][2][3][14]

Meet the patient

A 71-year-old retired teacher has taken temazepam 20 mg every night since her husband died in 2014. She has never taken more than prescribed, never asked for an early script, and never thought of herself as having a drug problem.[1][9]

She has fallen twice this year. Her daughter says she repeats herself. Her new GP has written "stop temazepam" on the discharge summary.[9][10][11]

Both things are true at once: she is physiologically dependent, and she has done nothing wrong. Getting that sentence right is the whole topic — because the plan that follows it is completely different from the plan that follows "she is addicted".[1][8][14]

Fellowship candidates must hold two truths simultaneously: short-term, indication-limited use can be legitimate and life-saving (severe acute anxiety, alcohol withdrawal protocols, procedural sedation), while chronic unsupervised use drives falls, cognitive harm, dependence and overdose synergy with other depressants.[1][8][16]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References18ShowHide
  1. [1]Soyka M. Treatment of Benzodiazepine Dependence N Engl J Med, 2017.PMID 28614686
  2. [2]Brett J, Murnion B. Management of benzodiazepine misuse and dependence Aust Prescr, 2015.PMID 26648651
  3. [3]Ashton H. The diagnosis and management of benzodiazepine dependence Curr Opin Psychiatry, 2005.PMID 16639148
  4. [4]Voshaar RC, Couvée JE, van Balkom AJ, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis Br J Psychiatry, 2006.PMID 16946355
  5. [5]Darker CD, Sweeney BP, Barry JM, et al. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence Cochrane Database Syst Rev, 2015.PMID 26106751
  6. [6]Baandrup L, Ebdrup BH, Rasmussen JØ, et al. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users Cochrane Database Syst Rev, 2018.PMID 29543325
  7. [7]Lader M, Kyriacou A. Withdrawing Benzodiazepines in Patients With Anxiety Disorders Curr Psychiatry Rep, 2016.PMID 26733324
  8. [8]Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol, 2014.PMID 22882333
  9. [9]Markota M, Rummans TA, Bostwick JM, et al. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies Mayo Clin Proc, 2016.PMID 27814838
  10. [10]Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits BMJ, 2005.PMID 16284208
  11. [11]Barker MJ, Greenwood KM, Jackson M, et al. Cognitive effects of long-term benzodiazepine use: a meta-analysis CNS Drugs, 2004.PMID 14731058
  12. [12]Pottie K, Thompson W, Davies S, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline Can Fam Physician, 2018.PMID 29760253
  13. [13]Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial JAMA Intern Med, 2014.PMID 24733354
  14. [14]Brunner E, Chen CA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits J Gen Intern Med, 2025.PMID 40526204
  15. [15]Fluyau D, Revadigar N, Manobianco BE. Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation Ther Adv Psychopharmacol, 2018.PMID 29713452
  16. [16]Guina J, Merrill B. Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives J Clin Med, 2018.PMID 29385731
  17. [17]Billioti de Gage S, Bégaud B, Bazin F, et al. Benzodiazepine use and risk of dementia: prospective population based study BMJ, 2012.PMID 23045258
  18. [18]Ashton H. Benzodiazepine withdrawal: an unfinished story Br Med J (Clin Res Ed), 1984.PMID 6143582

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAnti-craving pharmacotherapy (naltrexone, acamprosate, disulfiram)Addiction psychiatryNextADHD across the lifespanChild and adolescent psychiatry — neurodevelopmental